Optum notable drugs nearing FDA approval include Anaphylm, Sotyktu, and insulin icodec with decisions expected early 2026.

All 16 drug companies that inked deals with the Trump administration over the past few months still raised some of their ...

When eating, the body converts extra calories, especially from carbs, sugar, fats, and alcohol, into triglycerides.

Questions remain among top Food and Drug Administration officials over who has the appropriate legal authority to sign off on ...

The Journal of Clinical Pharmacology (JCP), the flagship journal of the American College of Clinical Pharmacology® (ACCP), proudly celebrates its 65th anniversary, marking more than six decades of ...

Despite longstanding guidelines, many dementia patients are still prescribed brain-altering medications that can raise the ...

“The projects awarded pilot studies grants for 2026 address important clinical and translational science questions,” says CTSI Director Sanjay Sethi, MD, SUNY Distinguished Professor of medicine and ...

Immunotherapy is offering new hope for cancers that once had grim prognoses by harnessing the body's own immune system to ...

Research reveals most Americans don't know the risks: here, experts list some vitamins, supplements, and medications not to ...

In Jeffersonville, on Monday, which is National Pharmacist Day, several pharmacists worked again at a local facility pushing ...

Novel next-generation Bruton tyrosine kinase (BTK)-targeted protein degrader APG-3288 has received investigational new drug ...

Atossa Therapeutics ( ($ATOS) ) has issued an update. On January 6, 2026, Atossa Therapeutics announced that the U.S. Food ...